Detection and molecular mass determination of an HIV replication-enhancing female genital tract factor using a blot bioassay

We previously reported that cervicovaginal lavages (CVL) contain a factor that enhances the replication of human immunodeficiency virus (HIV) by increasing virus transcription in T cells and monocytoid cells. This factor was named the HIV-inducing factor (HIF). To determine the molecular mass of HIF...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1988. - 28(2000), 3 vom: 14. März, Seite 478, 480, 482, 484 passim
1. Verfasser: Hashemi, F B (VerfasserIn)
Weitere Verfasser: Spear, G T, Madsen, L, Mollenhauer, J
Format: Aufsatz
Sprache:English
Veröffentlicht: 2000
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article Research Support, U.S. Gov't, P.H.S.
LEADER 01000naa a22002652 4500
001 NLM106511238
003 DE-627
005 20231222141019.0
007 tu
008 231222s2000 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0355.xml 
035 |a (DE-627)NLM106511238 
035 |a (NLM)10723560 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Hashemi, F B  |e verfasserin  |4 aut 
245 1 0 |a Detection and molecular mass determination of an HIV replication-enhancing female genital tract factor using a blot bioassay 
264 1 |c 2000 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 27.04.2000 
500 |a Date Revised 28.09.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a We previously reported that cervicovaginal lavages (CVL) contain a factor that enhances the replication of human immunodeficiency virus (HIV) by increasing virus transcription in T cells and monocytoid cells. This factor was named the HIV-inducing factor (HIF). To determine the molecular mass of HIF, we adapted a blot technique that involves nonreducing SDS-PAGE of CVL samples and electrophoretic transfer onto nitrocellulose paper followed by incubation of paper slices with HIV-infected monocytoid U1 cells. The slices with HIF bioactivity were detected by increased HIV production and measured by an HIV core protein (p24) ELISA. We refer to this technique as the "BioBlot" assay. The BioBlot assay successfully detected bioactivity of HIF anchored onto nitrocellulose and determined that HIF has a molecular mass of about 14 kDa. Paper slices with HIF-negative CVL samples as well as nitrocellulose paper samples without CVL did not enhance HIV production. This finding suggested that SDS-PAGE and nitrocellulose binding do not functionally alter the bioactive domain(s) of HIF structure. In addition to the detection of HIF bioactivity anchored to nitrocellulose and HIF molecular mass determination, the BioBlot technique offers an alternative, rapid method for other applications. These include the study of receptor-ligand interactions of mucosal proteins, direct bioactivity testing and molecular mass determination of secretory substances 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
700 1 |a Spear, G T  |e verfasserin  |4 aut 
700 1 |a Madsen, L  |e verfasserin  |4 aut 
700 1 |a Mollenhauer, J  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1988  |g 28(2000), 3 vom: 14. März, Seite 478, 480, 482, 484 passim  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnns 
773 1 8 |g volume:28  |g year:2000  |g number:3  |g day:14  |g month:03  |g pages:478, 480, 482, 484 passim 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 28  |j 2000  |e 3  |b 14  |c 03  |h 478, 480, 482, 484 passim